Hofheinz, R., Horisberger, K., Woernle, C., Wenz, F., Kraus-Tiefenbacher, U., Kähler, G., . . . Willeke, F. (2006). Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. International journal of radiation oncology, biology, physics, 66(5), . https://doi.org/10.1016/j.ijrobp.2006.07.005
Chicago-Zitierstil (17. Ausg.)Hofheinz, Ralf-Dieter, et al. "Phase I Trial of Cetuximab in Combination with Capecitabine, Weekly Irinotecan, and Radiotherapy as Neoadjuvant Therapy for Rectal Cancer." International Journal of Radiation Oncology, Biology, Physics 66, no. 5 (2006). https://doi.org/10.1016/j.ijrobp.2006.07.005.
MLA-Zitierstil (9. Ausg.)Hofheinz, Ralf-Dieter, et al. "Phase I Trial of Cetuximab in Combination with Capecitabine, Weekly Irinotecan, and Radiotherapy as Neoadjuvant Therapy for Rectal Cancer." International Journal of Radiation Oncology, Biology, Physics, vol. 66, no. 5, 2006, https://doi.org/10.1016/j.ijrobp.2006.07.005.